Do analysts rate BEAT or SONX?

HeartBeam presently has a consensus target price of $4.00, suggesting a potential upside of 928.54%. Given HeartBeam's stronger consensus rating and higher probable upside, analysts plainly believe HeartBeam is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartBeam 1 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.56 Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is BEAT or SONX more profitable?

HeartBeam has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat HeartBeam's return on equity. Company Net Margins Return on Equity Return on Assets HeartBeam N/A -686.78% -348.65% Sonendo -92.74% -184.01% -68.60%

Does the media refer more to BEAT or SONX?

In the previous week, HeartBeam had 3 more articles in the media than Sonendo. MarketBeat recorded 4 mentions for HeartBeam and 1 mentions for Sonendo. Sonendo's average media sentiment score of 0.00 beat HeartBeam's score of -0.67 indicating that Sonendo is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartBeam 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Negative Sonendo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate SONX or FEMY?

Femasys has a consensus target price of $50.00, indicating a potential upside of 1,837.98%. Given Femasys' stronger consensus rating and higher possible upside, analysts plainly believe Femasys is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Femasys 1 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.50

Which has preferable valuation and earnings, SONX or FEMY?

Femasys has lower revenue, but higher earnings than Sonendo. Femasys is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sonendo $44.40M 0.20 -$60.92M -$71.12 N/A Femasys $2.29M 9.44 -$18.63M -$3.53 N/A

Is SONX or FEMY more profitable?

Sonendo has a net margin of -92.74% compared to Femasys' net margin of -534.36%. Sonendo's return on equity of -184.01% beat Femasys' return on equity. Company Net Margins Return on Equity Return on Assets Sonendo -92.74% -184.01% -68.60% Femasys -534.36% -225.97% -74.68%

Does the media refer more to SONX or FEMY?

In the previous week, Sonendo and Sonendo both had 1 articles in the media. Sonendo's average media sentiment score of 0.00 equaled Femasys'average media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sonendo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Femasys 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate SONX or LFWD?

Lifeward has a consensus price target of $10.00, suggesting a potential upside of 41.34%. Given Lifeward's stronger consensus rating and higher possible upside, analysts plainly believe Lifeward is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Lifeward 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Which has stronger valuation and earnings, SONX or LFWD?

Lifeward has lower revenue, but higher earnings than Sonendo. Lifeward is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sonendo $44.40M 0.20 -$60.92M -$71.12 N/A Lifeward $22.03M 0.91 -$19.91M -$16.82 N/A

Is SONX or LFWD more profitable?

Sonendo has a net margin of -92.74% compared to Lifeward's net margin of -141.28%. Sonendo's return on equity of -184.01% beat Lifeward's return on equity. Company Net Margins Return on Equity Return on Assets Sonendo -92.74% -184.01% -68.60% Lifeward -141.28% -235.86% -81.72%

Do analysts recommend SONX or MODD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is SONX or MODD more profitable?

Modular Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat Modular Medical's return on equity. Company Net Margins Return on Equity Return on Assets Sonendo -92.74% -184.01% -68.60% Modular Medical N/A -292.14% -222.79%

Does the media prefer SONX or MODD?

In the previous week, Sonendo and Sonendo both had 1 articles in the media. Modular Medical's average media sentiment score of 0.67 beat Sonendo's score of 0.00 indicating that Modular Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sonendo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Modular Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate HSCS or SONX?

HeartSciences currently has a consensus price target of $8.00, suggesting a potential upside of 76.99%. Given HeartSciences' stronger consensus rating and higher probable upside, analysts clearly believe HeartSciences is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score HeartSciences 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is HSCS or SONX more profitable?

HeartSciences has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat HeartSciences' return on equity. Company Net Margins Return on Equity Return on Assets HeartSciences N/A -816.90% -181.97% Sonendo -92.74% -184.01% -68.60%

Does the media favor HSCS or SONX?

In the previous week, HeartSciences had 11 more articles in the media than Sonendo. MarketBeat recorded 12 mentions for HeartSciences and 1 mentions for Sonendo. HeartSciences' average media sentiment score of 0.86 beat Sonendo's score of 0.00 indicating that HeartSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment HeartSciences 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sonendo 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Sonendo (SONX) Competitors

$1.89 +0.19 (+11.18%)

As of 09/23/2026 02:09 PM Eastern

Compare

SONX vs. BEAT, FEMY, LFWD, MODD, and HSCS

Should you buy Sonendo stock or one of its competitors? Sonendo's main competitors and comparable companies include HeartBeam (BEAT), Femasys (FEMY), Lifeward (LFWD), Modular Medical (MODD), and HeartSciences (HSCS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sonendo compare to HeartBeam?

HeartBeam (NASDAQ:BEAT) and Sonendo (NYSE:SONX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, earnings, analyst recommendations, media sentiment, institutional ownership, dividends, valuation and risk.

HeartBeam has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat HeartBeam's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartBeam	N/A	-686.78%	-348.65%
Sonendo	-92.74%	-184.01%	-68.60%

HeartBeam has higher earnings, but lower revenue than Sonendo. HeartBeam is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartBeam	N/A	N/A	-$21.01M	-$0.51	N/A
Sonendo	$44.40M	0.20	-$60.92M	-$71.12	N/A

HeartBeam has a beta of -0.8, suggesting that its share price is 180% less volatile than the broader market. Comparatively, Sonendo has a beta of 1.81, suggesting that its share price is 81% more volatile than the broader market.

7.8% of HeartBeam shares are owned by institutional investors. Comparatively, 28.7% of Sonendo shares are owned by institutional investors. 18.0% of HeartBeam shares are owned by insiders. Comparatively, 7.9% of Sonendo shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, HeartBeam had 3 more articles in the media than Sonendo. MarketBeat recorded 4 mentions for HeartBeam and 1 mentions for Sonendo. Sonendo's average media sentiment score of 0.00 beat HeartBeam's score of -0.67 indicating that Sonendo is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HeartBeam	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Negative
Sonendo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

HeartBeam presently has a consensus target price of $4.00, suggesting a potential upside of 928.54%. Given HeartBeam's stronger consensus rating and higher probable upside, analysts plainly believe HeartBeam is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartBeam	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.56
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

HeartBeam beats Sonendo on 9 of the 16 factors compared between the two stocks.

How does Sonendo compare to Femasys?

Sonendo (NYSE:SONX) and Femasys (NASDAQ:FEMY) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, media sentiment, analyst recommendations, institutional ownership and dividends.

Sonendo has a beta of 1.81, meaning that its share price is 81% more volatile than the broader market. Comparatively, Femasys has a beta of -2.07, meaning that its share price is 307% less volatile than the broader market.

Femasys has a consensus target price of $50.00, indicating a potential upside of 1,837.98%. Given Femasys' stronger consensus rating and higher possible upside, analysts plainly believe Femasys is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

Sonendo has a net margin of -92.74% compared to Femasys' net margin of -534.36%. Sonendo's return on equity of -184.01% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Femasys	-534.36%	-225.97%	-74.68%

Femasys has lower revenue, but higher earnings than Sonendo. Femasys is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.20	-$60.92M	-$71.12	N/A
Femasys	$2.29M	9.44	-$18.63M	-$3.53	N/A

In the previous week, Sonendo and Sonendo both had 1 articles in the media. Sonendo's average media sentiment score of 0.00 equaled Femasys'average media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sonendo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Femasys	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

28.7% of Sonendo shares are owned by institutional investors. Comparatively, 65.3% of Femasys shares are owned by institutional investors. 7.9% of Sonendo shares are owned by insiders. Comparatively, 7.8% of Femasys shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Sonendo and Femasys tied by winning 7 of the 14 factors compared between the two stocks.

How does Sonendo compare to Lifeward?

Sonendo (NYSE:SONX) and Lifeward (NASDAQ:LFWD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, risk, dividends, media sentiment, valuation and profitability.

Lifeward has lower revenue, but higher earnings than Sonendo. Lifeward is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.20	-$60.92M	-$71.12	N/A
Lifeward	$22.03M	0.91	-$19.91M	-$16.82	N/A

Sonendo has a beta of 1.81, meaning that its stock price is 81% more volatile than the broader market. Comparatively, Lifeward has a beta of 0.39, meaning that its stock price is 61% less volatile than the broader market.

Lifeward has a consensus price target of $10.00, suggesting a potential upside of 41.34%. Given Lifeward's stronger consensus rating and higher possible upside, analysts plainly believe Lifeward is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Lifeward	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Sonendo has a net margin of -92.74% compared to Lifeward's net margin of -141.28%. Sonendo's return on equity of -184.01% beat Lifeward's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Lifeward	-141.28%	-235.86%	-81.72%

In the previous week, Sonendo had 1 more articles in the media than Lifeward. MarketBeat recorded 1 mentions for Sonendo and 0 mentions for Lifeward. Sonendo's average media sentiment score of 0.00 equaled Lifeward'saverage media sentiment score.

Company	Overall Sentiment
Sonendo	Neutral
Lifeward	Neutral

28.7% of Sonendo shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 7.9% of Sonendo shares are held by insiders. Comparatively, 1.5% of Lifeward shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Sonendo beats Lifeward on 9 of the 15 factors compared between the two stocks.

How does Sonendo compare to Modular Medical?

Sonendo (NYSE:SONX) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

28.7% of Sonendo shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 7.9% of Sonendo shares are held by company insiders. Comparatively, 7.1% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Modular Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Modular Medical	N/A	-292.14%	-222.79%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Sonendo has a beta of 1.81, meaning that its share price is 81% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.45, meaning that its share price is 55% less volatile than the broader market.

Modular Medical has lower revenue, but higher earnings than Sonendo. Modular Medical is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.20	-$60.92M	-$71.12	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

In the previous week, Sonendo and Sonendo both had 1 articles in the media. Modular Medical's average media sentiment score of 0.67 beat Sonendo's score of 0.00 indicating that Modular Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sonendo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Modular Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Sonendo beats Modular Medical on 7 of the 12 factors compared between the two stocks.

How does Sonendo compare to HeartSciences?

HeartSciences (NASDAQ:HSCS) and Sonendo (NYSE:SONX) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, media sentiment, dividends, institutional ownership, earnings, analyst recommendations, profitability and valuation.

17.2% of HeartSciences shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 4.9% of HeartSciences shares are held by company insiders. Comparatively, 7.9% of Sonendo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

HeartSciences has a beta of 1.85, meaning that its share price is 85% more volatile than the broader market. Comparatively, Sonendo has a beta of 1.81, meaning that its share price is 81% more volatile than the broader market.

HeartSciences has higher earnings, but lower revenue than Sonendo. HeartSciences is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
HeartSciences	N/A	N/A	-$9.14M	-$3.22	N/A
Sonendo	$44.40M	0.20	-$60.92M	-$71.12	N/A

HeartSciences has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat HeartSciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
HeartSciences	N/A	-816.90%	-181.97%
Sonendo	-92.74%	-184.01%	-68.60%

In the previous week, HeartSciences had 11 more articles in the media than Sonendo. MarketBeat recorded 12 mentions for HeartSciences and 1 mentions for Sonendo. HeartSciences' average media sentiment score of 0.86 beat Sonendo's score of 0.00 indicating that HeartSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
HeartSciences	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Sonendo	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

HeartSciences currently has a consensus price target of $8.00, suggesting a potential upside of 76.99%. Given HeartSciences' stronger consensus rating and higher probable upside, analysts clearly believe HeartSciences is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HeartSciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

HeartSciences beats Sonendo on 9 of the 15 factors compared between the two stocks.

Get Sonendo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SONX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SONX vs. The Competition

Export

Metric	Sonendo	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$9.03M	$5.58B	$7.31B	$23.09B
Dividend Yield	N/A	1.79%	2.52%	3.61%
P/E Ratio	-0.03	25.26	274.07	28.10
Price / Sales	0.20	71.57	643.13	20.14
Price / Cash	N/A	33.02	77.80	38.68
Price / Book	0.02	5.78	10.47	4.66
Net Income	-$60.92M	$151.55M	$3.49B	$1.07B
7 Day Performance	N/A	0.01%	-0.67%	-1.27%
1 Month Performance	225.86%	-3.51%	-3.17%	-4.71%
1 Year Performance	656.00%	6.37%	15.13%	7.48%

Sonendo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SONX Sonendo	N/A	$1.89 +11.2%	N/A	+656.0%	$9.03M	$44.40M	N/A	250
BEAT HeartBeam	3.0914 of 5 stars	$0.42 +0.5%	$4.00 +847.9%	-76.1%	$23.78M	N/A	N/A	1,700	News Coverage Analyst Downgrade Gap Down
FEMY Femasys	2.8055 of 5 stars	$2.52 -0.7%	$50.00 +1,882.6%	-62.5%	$21.36M	$2.30M	N/A	54	News Coverage
LFWD Lifeward	1.9668 of 5 stars	$7.20 +4.2%	$10.00 +38.9%	-13.7%	$19.57M	$22.03M	N/A	81	Gap Up
MODD Modular Medical	1.1429 of 5 stars	$2.25 -2.6%	N/A	-89.7%	$18.79M	N/A	N/A	51	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SONX) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sonendo (SONX) Competitors